3M MATERIAL SAFETY DATA SHEET 3M Black Inkjet Ink 5495
explode. Hazardous polymerization may occur.
severe skin irritation.
3.2 POTENTIAL HEALTH EFFECTS
Eye Contact:
Severe Eye Irritation: Signs/symptoms may include significant redness, swelling, pain, tearing, cloudy appearance of the cornea, and
impaired vision.
Skin Contact:
Severe Skin Irritation: Signs/symptoms may include localized redness, swelling, itching, dryness, cracking, blistering, and pain.
Allergic Skin Reaction (non-photo induced): Signs/symptoms may include redness, swelling, blistering, and itching.
Inhalation:
Respiratory Tract Irritation: Signs/symptoms may include cough, sneezing, nasal discharge, headache, hoarseness, and nose and
throat pain.
Ingestion:
Gastrointestinal Irritation: Signs/symptoms may include abdominal pain, stomach upset, nausea, vomiting and diarrhea.
Carcinogenicity:
Contains a chemical or chemicals which can cause cancer.
Ingredient
CARBON BLACK
SECTION 4: FIRST AID MEASURES
4.1 FIRST AID PROCEDURES
The following first aid recommendations are based on an assumption that appropriate personal and industrial hygiene practices are
followed.
Eye Contact: Immediately flush eyes with large amounts of water for at least 15 minutes. Get immediate medical attention.
Skin Contact: Remove contaminated clothing and shoes. Immediately flush skin with large amounts of water. Get medical
attention. Wash contaminated clothing and clean shoes before reuse.
Inhalation: Remove person to fresh air.
If Swallowed:
Do not induce vomiting unless instructed to do so by medical personnel. Give victim two glasses of water. Never
give anything by mouth to an unconscious person. Get medical attention.
SECTION 5: FIRE FIGHTING MEASURES
_________________________________________________________________________________________________
May cause severe eye irritation. May cause allergic skin reaction. May cause
Contains a chemical or chemicals which can cause cancer.
C.A.S. No.
1333-86-4
If signs/symptoms develop, get medical attention.
03/12/2007
Class Description
Group 2B
Regulation
International Agency for Research on Cancer
Page
2 of 7